Key changes to the Integrated MAPS PDS from 27 February 2024

We would like to inform you that we are making the below changes to the Product Disclosure Statement (PDS) of the Integrated Managed Account Portfolio Service (MAPS) on 27 February 2024.

Capitalised terms used in this document have the same meaning as in the PDS.

The key changes include, but are not limited to, the following:

  • Updated disclosure of fees and costs — While there have been no changes to the fee structure that applies to MAPS, our estimates of certain fees and costs have been updated following our latest review to ensure that they accurately reflect the costs of managing the scheme.
  • Redemptions and transfers — At the discretion of the Responsible Entity and the Nominated Platform, the Responsible Entity and Portfolio Manager may allow (at any time):
    • a redemption from the MAPS Real Assets Portfolio in special circumstances (for example, a deceased estate or hardship for the Investor, an SMSF closure, etc.);
    • a redemption from the MAPS Real Assets Portfolio if the equivalent redemption amount is available for investment from a Holding Investment Portfolio; or
    • a transfer from the MAPS Real Assets Portfolio to another MAPS Investment Portfolio that may or may not have the same beneficial ownership (noting a change in the beneficial ownership may trigger capital gains tax consequences for the Investor), provided there are no material negative impacts on the remaining investors in the Investment Portfolio and the Underlying Asset.
  • Minimum Investment Amount —  If, at any time, the value of your Investment Portfolio falls below the minimum investment amount, the Responsible Entity may, on your behalf, redeem your entire Investment Portfolio.
  • Termination of participation in MAPS — The Responsible Entity may, in its absolute discretion, terminate your participation in MAPS at any time by providing you with written notice. Where this occurs, we will realise the Underlying Assets in your MAPS Portfolio and distribute the net proceeds to you.  
  • Amendments to the descriptions of the MAPS Portfolios – Enhancements have been made to the investment objective and benchmark disclosure to provide further clarification. Importantly, there have been no changes to the way in which these Portfolios are being managed.

Full details of the above changes can be found in the updated PDS. As always, we recommend that you read this document carefully to understand the main benefits and risks of investing, along with other features of the scheme.

You can view and download the updated PDS here

Integrated MAPS Target Market Determination (TMD)

What is a Target Market Determination?

A Target Market Determination (TMD) is a document which describes the type of investor who may be suitable for a particular financial product (the target market).

A TMD includes the following information:

  • Which type of investor is likely to buy the product, including their ability to meet their financial obligations and endure financial loss;
  • Who can distribute the product; and
  • Situations when the product and the target market may need to be reviewed.

It is important that you understand that a TMD does not replace disclosure documents such as the relevant PDS for the product. You should, therefore, continue to refer to, and read in its entirety, the relevant PDS before deciding whether to acquire the product.

Have there been any changes made to the MAPS TMD as part of the upcoming PDS update?

No changes have been made to the MAPS TMD as part of the upcoming MAPS PDS update. The MAPS TMD will be re-issued in tandem with the MAPS PDS on 27 February 2024.

You can view and download the MAPS TMD here

Queries

If you have any queries relating to the information provided in this notice, please contact Atrium via:

Telephone: (02) 9248 8090
Email: investors@atriuminvest.com.au
Website: www.atriuminvest.com.au

Disclaimer: This notice should not be taken as advice and does not take into account the personal financial situation, objectives or needs of any person. Before deciding whether to invest or remain invested, we strongly recommend that you seek advice from a financial adviser.

Important Information

This information has been prepared and issued by Atrium Investment Management Pty Ltd (ABN 17 137 088 745, AFSL 338 634) (Atrium) as the investment manager of the Marketing Name: Atrium Evolution Risk Targeted Fund. Registered Name: Atrium Evolution Series – Diversified Fund (ARSN151 191 776), Integrated Managed Account Portfolio Service (ARSN 627 688 402) (MAPS) and the Colonial First State Separately Managed Account (ARSN 618 390 051) (CFS SMA).

The information is general information only and is not intended to provide you with financial advice and has been prepared without taking into account your objectives, financial situation or needs. You should consider the product disclosure statement (PDS), prior to making any investment decisions. The PDS and target market determination (TMD) can be obtained by visiting our website atriuminvest.com.au. If you require financial advice that takes into account your personal objectives, financial situation or needs, you should consult your licensed or authorised financial adviser. his information is only as current as the date indicated, and may be superseded by subsequent market events or for other reasons. To the extent permitted by law, no liability is accepted for any loss or damage as a result of any reliance on this information. All investments contain risk and may lose value.

The Trust Company (RE Services) Limited (ABN 45 003 278 831, AFSL 235150) is the Responsible Entity (RE) of the Atrium Evolution Series – Diversified Fund (ARSN 151 191 776), Integrated Managed Account Portfolio Service (ARSN 627 688 402) (MAPS), Atrium Enhanced Fixed Income Fund (ARSN 616 127112) and Atrium Alternatives Fund (ARSN 616 126 982). Investors should consider the PDS and TMD (available from Atrium’s website) before making any investment decisions.

Colonial First State Investments Limited (ABN 98 002 348 352, AFSL 232468 ) is the Responsible Entity (RE) of the Colonial First State Separately Managed Account (ARSN 618 390 051) (CFS SMA). Atrium is the portfolio manager of each of the aforementioned portfolios. Investors should consider the relevant offering document (Product Disclosure Statement (PDS) or Information Memorandum (IM) as appropriate), Target Market Determination (TMD) and other relevant information available from Atrium before making any investment decision. Investments in the CFS SMA are only available on CFS Edge. Investors should consider the PDS and TMD before making any investment decisions. Applications for a portfolio in the CFS SMA can only be made pursuant to the application form attached to the relevant PDS or Investor Directed Portfolio Service (IDPS) guide (CFS SMA Offer Documents). Please refer to the CFS SMA Offer Documents for important information concerning an investment in the CFS SMA.

You can only invest in MAPS through HUB24 Invest, an IDPS operated and administered by HUB24 Custodial Services Ltd (ABN 94 073 633 664, AFSL239122) (HUB24 Custodial Services), or through HUB24 Super, a super investment service offered through the HUB24 Super Fund (ABN 60 910 190 523, RSER1074659, USI 60 910 190 523 001) (‘Nominated Platform’ means either HUB24 Invest or HUB24 Super). HUB24 Custodial Services is the promoter of theHUB24 Super Fund and provides a range of services to the HUB24 Super Fund. Investors should consider the MAPS PDS and TMD (available from the Nominated Platform’s and Atrium’s website) before making any investment decision. Please refer to the disclosure documents for your Nominated Platform(available from your financial adviser or your Nominated Platform) together with the PDS for important information concerning an investment in MAPS.

Search for